Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman B Gaylis, MD
Arthritis & Rheumatic Disease Specialties
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Guillermo Valenzuela Md
Fort Lauderdale, Florida, United States
- Drs. Charles Kahn and Wayne Riskin
Hollywood, Florida, United States
- Arhtritis & Rheumatic Disease Specialties
Miami, Florida, United States
- Arthritis and Rheumatology Clinics of Kansas
Wichita, Kansas, United States
- Mcbride Clinic Orthopedic Center
Oklahoma City, Oklahoma, United States
- Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2007
- Primary completion
- 30 Nov 2011
- Completion
- 30 Nov 2012
- Last update posted
- 22 Aug 2013
- Registered enrollment
- 60
- Registry id
- NCT00425932
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.